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Abstract 
 
Patients with cancer are emotionally affected during their cancer treatment course. Sometimes, 
patient’s psychological issues are overlooked during the actual disease treatment. Cancer patients 
are at a higher risk of developing anxiety and depression (A&D). A presumptive diagnosis of 
anxiety and depression was assessed based on a useful tool, the 14 item Hospital Anxiety and 
Depression Scale (HADS). Patient responses were assessed for the prevalence of anxiety and 
depression. In all, 102 patients were studied using the questionnaires of HADS. The 
demographic and clinical details were collected from patients. Breast cancer patients had the 
highest prevalence of anxiety (31.6%) and depression (32.4%) among all other cancer patients. 
Furthermore, cancer patients experienced more anxiety problems than depression. There is a 
significant relationship between gender and anxiety (p = .0144), with females experiencing more 
anxiety problems than males. 36.2% of patients did not discuss their psychological problems 
with their oncologist, and 60.8% of patients did not receive any treatment for anxiety and/or 
depression. Younger patients (< 45 years of age, 50%), males (46.5%), and American Indians 
(62.5%) received treatment more frequently for anxiety and depression alongside their cancer 
treatment. Managing the symptoms of anxiety and depression in cancer patients helps in 
promoting their quality of life and improving the prognosis of the disease. So, it is very 
important for oncologists to understand the cancer patient’s psychological state while giving 
cancer treatment.
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Chapter 1: Introduction 
 
 
 
Although cancer treatment technology has advanced during the past several years, many 
patients diagnosed with cancer feel that their lives are ending. Patients are distressed and become 
emotionally compromised, leading to anxiety and depression (A&D). A&D are the two most 
common psychiatric comorbidities found among cancer patients (Pagoto, 2011). 
 
Sometimes, the patient’s psychological issues are overlooked during their actual disease 
treatment. The primary goal of those involved in cancer treatment is to eradicate the physical 
symptoms, not necessarily to support the patient emotionally. According to Dr. Rashid (2012), a 
cancer diagnosis triggers anxiety in up to 40% of patients. Other articles report, the prevalence of 
A&D in cancer patients as ranging from 25% to 54% (Massie, 2004; Takahashi et al., 2008; 
Pascoe, Edelman, & Kidman, 2000; Tagay et al., 2006; Clinton-McHarg et al., 2014). The 
symptoms of anxiety vary from the patient to patient but include feeling fatigue, low appetite or 
overeating, feeling sad, disturbance in sleep or staying asleep, increased pain perception, 
irritability, loss of interest, etc. (Rashid, 2012). According to NCI’s Depression-Patient Version 
(PDQ), symptoms of depression include unexplained tiredness, guilty feelings, feeling worthless, 
frequent thoughts of death or suicide, etc. (Bethesda, 2016). 
 
If A&D is untreated, it may lead to hypertension (abnormally high blood pressure), a 
serious medical condition, and when these symptoms become overwhelming, they ultimately can 
lead to suicide attempts. Some previous studies have demonstrated an increased risk for 
psychiatric morbidity among cancer patients (Aass, Fossa, Dahl, & Aloe, 1997). Galloway et al. 
(2012) found that A&D triggers pain in breast cancer patients and limits their daily activities.
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Thus, it is very important to understand the cancer patient’s psychological status during 
treatment. 
 
Not all oncologists recommend that their cancer patients receive testing for symptoms of 
distress (Shimizu, 2013). The ultimate goal of this study was to demonstrate the importance of 
understanding the patient’s psychosocial needs in addition to treating their cancer. No previous 
studies have addressed the prevalence of A&D in all types of cancer patients and reported the 
percentage of patients getting treatment for A&D (Massie, 2004; Takahashi et al., 2008; 
Nikbakhsh, Moudi, Abbasian, & Khafri, 2014). Therefore, this research assessed the A&D 
prevalence in cancer patients. Early diagnosis of the condition may improve the effectiveness of 
cancer treatment (Adler, Page, & Institute of Medicine [U.S.], 2008). 
 
The burden of disease and its treatment drive cancer patients to withdraw from their 
families and other social support systems, which, in turn, may increase their distress and feelings 
of despair (American Society of Clinical Oncology [ASCO], 2012; http://www.cancer.net). As a 
standard of good cancer care, routine screening for distress is recommended internationally to 
accompany cancer treatment (Grassi et al., 2013). 
 
In this study, cancer patients who are currently under treatment completed an online 
survey about their A&D prevalence. Participants were assessed for their A&D with an 
instrument, Hospital Anxiety and Depression Scale (HADS). Zigmond and Snaith (1983) 
developed HADS to provide clinicians with an acceptable, reliable, valid, and simple tool to 
identify and quantify A&D in cancer patients (Stern, 2014). This survey included two additional 
questions asking whether patient discussed their psychological issues with their oncologists and 
whether they received treatment for A&D.
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Chapter 2: Thesis Statement 
 
 
Purpose of the Study 
 
 
The purpose of this research is to determine the prevalence of cancer-related anxiety and 
depression (A&D) in patients during their cancer treatment. A second aim of this study is also to 
find the percentage of patients receiving treatments for their anxiety/depression in addition to 
treatment for the actual cancer and how it relates to demographic characteristics. 
 
Research Questions 
 
Question 1 
 
What is the prevalence of A&D among cancer patients during their treatment period? 
 
 
Question 2 
 
Do patients discuss anxiety and depression treatment with their oncologist? 
 
 
Question 3 
 
Are there any significant relationships between A&D and age, ethnicity, type of cancer, or 
type of treatment patients are receiving for cancer?
4 
ANXIETY AND DEPRESSION IN CANCER PATIENTS 
4  
 
 
 
Chapter 3: Research Design and Methodology 
 
 
Design and Data Collection 
 
 
The survey link was posted on various social media sites upon approval by the Eastern 
Michigan University Human Subjects Review Committee (UHSRC; Appendix A). An URL for 
the survey via Question Pro® (an online survey website) for the survey was posted to the 
American Cancer Society and other cancer support groups (e.g., Cancer Support Community, 
Hopewell Cancer Support) on a Facebook page, Twitter, LinkedIn, and other social media sites 
(Appendix B). The survey link remained active online for three months. Cancer patients who 
are currently receiving various treatments for their cancer were eligible to take part in this study. 
Ineligible participants were redirected to the “Thank You” page, and were unable to see the 
survey questions. After completing the five demographic questions, two questions related to 
anxiety and depression scale and two questions related to anxiety and depression (A&D) 
management (see Appendix C), the participant was directed to click the “submit” button, which 
submits their anonymous answers.  Patients with cancer were assessed for anxiety and 
depression by using the Hospital Anxiety and Depression Scale (HADS). 
 
 
Study participants included a sample size of 100 patients with different cancer types, such 
as breast, prostate, gastrointestinal, leukemia/lymphoma, lung, skin, and bladder/kidney, 
currently receiving chemotherapy or radiation therapy or who had undergone surgery. 
Participants were asked to complete the survey questionnaire via various social media pages. 
Demographic data were collected, including age range, sex, ethnic group, type of cancer, and 
type of cancer treatment. The correlation was examined between demographic characteristics 
and the prevalence of anxiety and depression. Through a population size of a minimum of 
 
100,000 (combining members of all social media followers), 102 valid survey responses were
5 
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received from a total of 137 patients who attempted to respond to the survey. 
 
 
HADS Scale 
 
 
A presumptive diagnosis of anxiety and depression was based on a 4-point, 14-item 
Hospital Anxiety and Depression Scale (HADS). The HADS has two subscales for anxiety 
(seven items) and for depression (seven items; Snaith & Zigmond, 1986). For each item, the 
respondents were asked to choose which of four options (rated from 0 to 3) comes closest to 
describing how they have been feeling in the past week. Total scores of each subscale range 
from 0 to 21. The score of 0–7 means without clinical symptoms of anxiety or depression 
(normal), 8–10 mild anxiety or depression, 11–14 is a moderate range of anxiety or depression, 
and 15–21 indicates severe anxiety or depression. For the purpose of analysis, in this study 
mild, moderate, and severe anxiety or depression scores are taken together as symptomatic 
anxiety or depression. The data were collected and analyzed using SPSS Version 24. The 
outcomes were compared with socio-demographic data of the patients. 
 
Statistical Analysis 
 
 
The data were collected and analyzed using SPSS Version 24. The frequency and 
descriptive analysis as used to calculate the demographic and clinical distribution of patients. 
The one-way analysis of variance (ANOVA), independent t-test and chi-square analysis was 
carried out in order to evaluate the significant relationship of anxiety and depression with age, 
gender, ethnicity, type of cancer, and treatment type. For the purpose of analysis, severity levels 
of anxiety and depression were divided into two groups: those who scored 0–7 as normal and 
those who scored 8 and above as symptomatic anxiety or depression (Bjelland, Dahl, Haug, & 
Neckelmann, 2002).
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Chapter 4: Results 
 
 
Demographic Characteristics 
 
 
Patients who were currently under cancer treatment were eligible to respond to the 
survey. Out of 151 participants who attempted to respond, 102 valid responses were obtained. 
The demographic characteristics of the respondents are presented in Table 1. 
 
Table 1 
 
Overall Cancer Patient’s Demographic Characteristics 
 
Demographic characteristics Percent 
N
 
 
Response Rate 
 
Completed 
 
137 
 
 Valid 102 90.7% 
 Dropouts 14  
 Total 151  
Age 18–29 4 3.9% 
 30–44 14 13.7% 
 45–59 37 36.3% 
 60+ 47 46.1% 
Race/Ethnicity American Indian or Alaskan 
Native 
8 7.8% 
 Asian / Pacific Islander 15 14.7% 
 Hispanic 4 3.9% 
 White/Caucasian 62 60.9% 
 Black or African American 13 12.8% 
 Other 0 0.0% 
Gender Male 43 42.2% 
 Female 59 57.8% 
Where N=No. of patients
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Prevalence of Anxiety and Depression 
 
 
As seen in Table 2, 98 (96.1%) patients had symptomatic anxiety (anxiety score > 8), and 
but only 71 (69.6%) showed symptomatic depression (depression score > 8). The average 
anxiety score was 14.5 (SD = 3.3) and for depression was 9.5 (SD = 3.9) on the Hospital Anxiety 
and Depression Scale (HADS). The average scores indicated that patients were experiencing 
symptomatic anxiety and depression. In addition, 69.6% of patients were experiencing high 
frequencies of both anxiety and depression. The results indicate that cancer patients are 
experiencing more symptomatic anxiety problems than symptomatic depression during their 
course of cancer treatment. Most of the patients, 31 (30.39%) were undergoing combination 
therapy (combination of surgery, chemotherapy and radiation therapy) and 30 (29.41%) were 
undergoing radiation. The remaining patients are either taking chemotherapy or were scheduled 
for surgery (see Table 2). 
 
Table 2 
 
Overall Cancer Patient’s Clinical Characteristics 
 
 
Clinical characteristics                                                                                            N (%) 
 
 
Type of cancer 
 
Breast 
 
31 (30.4) 
 Prostate 13 (12.7) 
 Gastro 15 (14.7) 
 Leukemia 10 (9.8) 
 Lung 16 (15.6) 
 Skin 3 (2.9) 
 Bladder 5 (4.9) 
 Others 9 (8.8) 
 
Type of treatment 
 
Chemotherapy 
 
23 (22.5) 
 Radiation therapy 30 (29.4) 
 Surgery 18 (17.6) 
 Combination therapy 31 (30.4) 
8 
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Anxiety score                            Normal (0–7)                                                       4 (3.9) 
Symptomatic anxiety (8 and above)                    98 (96.1) 
 
Depression score                       Normal (0–7)                                                      31 (30.4) 
Symptomatic depression (8 and above)              71 (69.6) 
 
Where N=No. of patients 
 
Table 3 indicates that 43.9% of the 60 and above age group were reporting higher 
frequency of anxiety than any other age groups. 59.2% of females scored 8 and above on the 
HADS scale indicating the symptoms of anxiety, whereas 40.8% males were experiencing 
symptomatic anxiety. With regards to ethnicity, 61.2% of White and 14.3% of Asian populations 
were suffering from anxiety problems (see Table 3). 
 
Table 3 
 
Distribution of Anxiety Diagnosis by Age, Gender, and Ethnicity. 
 
 
 
Demographic characteristics                       Severity of Anxiety N (%) 
 
 Normal Symptomatic 
Anxiety 
Age 18–29 0(0.0) 4 (4.1) 
 
 
30–44 
 
0(0.0) 
 
14(14.3) 
 
 
45–59 
 
0(0.0) 
 
37(37.6) 
 
 
60 and above 
 
4(100) 
 
43(43.9) 
Gender Male 
 
3 (75) 
 
40 (40.8) 
 
Female 
 
1(25) 
 
58(59.2) 
 
Ethnicity 
 
American Indian 
 
0(0.0) 
 
8(8.2) 
 
 
Asian 
 
1(25) 
 
14(14.3) 
 
 
Hispanic 
 
0(0.0) 
 
4(4.1) 
 
 
White/Caucasian 
 
2 (50) 
 
60(61.2) 
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African 
American/ Black 
1(25)                    12(12.4)
 
Total N (%)                                4(100)                   98 (100) 
 
Where N=No. of patients 
 
In this study, 43.7% of the 60 and above age group patients were experiencing more 
depression than any other age groups. Sixty-three percent of females scored 8 and above on the 
HADS scale, indicating the symptoms of depression, whereas 36.6% males experiencing 
symptomatic depression. Sixty percent of White/Caucasian and 15.5% of Asian population 
reported a high frequency of depression. Overall, 30.4% of patients were normal and 69.6% of 
patients were suffering from depression problems during their cancer treatment (see Table 4). 
There were significant relationships between anxiety and gender (p = .014,  p < 0.05 at CI = 5%). 
Age had no influence on the occurence of anxiety and depression (p > 0.05). There is no 
significant relationship between anxiety/depression and ethnicity (p > 0.05), as all ethnic groups 
experienced severe anxiety and depression problems. 
 
Table 4 
 
Distribution of Depression by age, gender, and ethnicity. 
 
 
 
Demographic characteristics                        Severity of Depression N (%) 
 
 Normal Symptomatic 
Depression 
Age 18–29 1(3.2) 3(4.2) 
 
 
30–44 
 
2(6.5) 
 
12(16.9) 
 
 
45–59 
 
12(38.7) 
 
25(35.2) 
 
 
60 and above 
 
16(51.6) 
 
31(43.7) 
Gender Male 
 
17(54.8) 
 
26(36.6) 
10 
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 Female 14(45.2) 45(63.4) 
 
Ethnicity 
 
American Indian 
 
1(3.2) 
 
7(9.9) 
 
 
Asian 
 
4(12.9) 
 
11(15.5) 
 
 
Hispanic 
 
1(3.2) 
 
3(4.2) 
 
 
White/Caucasian 
 
19(61.3) 
 
43(60.6) 
 
 
African American/ 
Black 
 
6(19.4) 
 
7(9.9) 
Total N (%)  31(100) 71(100) 
Where N=No. of patients 
 
In this study, 71 of 98 patients suffered from symptomatic anxiety and depression, a high 
frequency of symptomatic anxiety and depression was observed in breast cancer patients 
(A: 31.6% and D: 32.4%), followed by gastrointestinal (A: 14.3%, D: 15.5%) and lung cancer 
patients (A: 15.3%, D: 14.1%; See Table5). 
Table 5 
 
Distribution of Anxiety and Depression Diagnosis in Different Types of Cancer 
Type of 
cancer                     
Normal
 
Symptomatic 
Anxiety/Depression         
Total
(0–7) (8–21)                        N
 
            N (%)                            N (%)                    
 
 A D  A  D  
Breast 0(0.0) 8(25.8)  31(31.6)  23(32.4)  31(30.4) 
 
Prostate 
 
1(25.0) 
 
8(25.8) 
  
12(12.2) 
  
5(7.0) 
  
13(12.7) 
 
Gastro 
 
1(25.0) 
 
4(12.9) 
 
 
14(14.3) 
 
 
11(15.5) 
  
15(14.7) 
 
Leukemia 
 
0(0.0) 
 
1(3.2) 
  
10(10.2) 
  
9(12.7) 
  
10(9.8) 
 
Lung 
 
1(25.0) 
 
6(19.4) 
  
15(15.3) 
  
10(14.1) 
  
16(15.7) 
 
Skin 
 
0(0.0) 
 
0(0.0) 
  
3(3.1) 
  
3(4.2) 
  
3(2.9) 
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Bladder 1(25.0) 2(6.5) 4(4.1) 3(4.2) 5(4.9) 
 
Others 
 
0(0.0) 
 
2(6.5) 
 
9(9.9) 
 
7(9.9) 
 
9(8.8) 
Total N (%) 4(100) 31(100) 98(100) 71(100) 102(100) 
Where N=No. of patients 
 
 
Patients who received chemotherapy as a single treatment reported more symptomatic 
anxiety (95.6%) and more symptomatic depression (45.1%) than was observed in cancer patients 
who received combination therapies (see Table 6). 
Table 6 
 
Distribution of Anxiety and Depression with Different Types of Cancer Treatments 
 
 
 
Type of cancer 
treatments 
Normal 
(0–7) 
 
N (%) 
Symptomatic 
Anxiety/Depression 
(8–21) 
N (%) 
Total
 
Chemotherapy               *A:1(25.0) 
**D:8 (25.8) 
A: 22(22.3) 
 
D: 15(21.1) 
23(22.5)
 
 
Radiation therapy           A:1(25.0) 
D:4(12.9) 
A:29(29.6) 
 
D:26(36.6) 
30(29.4)
 
 
Surgery                           A:2(50.0) 
D:10 (32.2) 
A:16 (16.3) 
 
D:8 (11.3) 
18(17.6)
 
 
Combination therapy      A: 0 (0.0) 
D:9 (29.0) 
A:31 (31.6) 
 
D:22 (30.1) 
31(30.4)
 
 
Total N (%)                    A:4(100) 
D:31(100) 
A:98(100) 
 
D:71(100) 
102(100)
 
Where N=No. of patients *A: Anxiety **D: Depression
12 
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Although there were indications of possible differences, anxiety and depression showed 
no association with type of cancer and type of treatment (P > 0.05). But for patients undergoing 
combination therapy, they showed a high frequency of anxiety (31.6%) with radiation therapy 
patients showing the highest prevalence of depression (36.6%). 
 
Patients’ Perception of Anxiety and Depression Management 
 
 
Of the respondent patients, 63.7% reported that they discussed their symptoms and 
treatment for anxiety and depression with their oncologists (see Table 7). Overall, only 39.2% of 
patients received some treatment for anxiety and depression reduction and 60.8% of patients did 
not receive any treatment. Of those who discussed their symptoms with oncologists, 38.46% 
reported that no treatment was recommended by their oncologists (see Table 8). Fifty percent of 
the younger patients (< 45years of age) received some treatment for anxiety and depression 
within their population. Males received treatment more frequently (46.5%) compared to females 
(33.9%), and American Indians (62.5%) and Asians (46.6%) received treatment more frequently 
than Caucasians (38.7%), African Americans/Blacks (30.8%), or Hispanics (0%). 
 
Table 7 
 
Overall Number of Patients Received Treatment for Anxiety and Depression 
 
 
AD Management 
  
N (%) 
 
Patients discussed AD with 
 
YES 
 
65 (63.7) 
oncologists? NO 37 (36.2) 
 
Patients received treatment 
 
YES 
 
40 (39.2) 
for AD after discussion? NO 62 (60.8) 
13 
ANXIETY AND DEPRESSION IN CANCER PATIENTS 
 
 
 
 
Table 8 
 
Number of Patients Received Treatment for Their Anxiety and Depression by Demographic 
Characteristics 
Demographics 
characteristics 
Did patient receive any 
treatment for AD after 
discussion? 
N (%)
YES                      NO Total
 
N (%)                  N (%) N (%) 
 
 
 
Age 
 
 
 
18–29 
 
 
 
2 (50.0) 
 
 
 
2 (50.0) 
 
 
 
4 (100) 
 
 
30–44 
 
7 (50.0) 
 
7 (50.0) 
 
14 (100) 
 
 
45–59 
 
14 (37.8) 
 
23 (62.1) 
 
37 (100) 
 
 
60 and above 
 
17 (36.2) 
 
30 (63.8) 
 
47 (100) 
 
Gender 
 
Male 
 
20 (46.5) 
 
23 (53.5) 
 
43 (100) 
 
Female 
 
20 (33.9) 
 
39 (66.1) 
 
59 (100) 
Ethnicity 
 
American Indian 
 
5 (62.5) 
 
3 (37.5) 
 
8 (100) 
 
 
Asian 
 
7 (46.6) 
 
8 (53.3) 
 
15 (100) 
 
 
Hispanic 
 
0 (0.00) 
 
4 (100) 
 
4 (100) 
 
 
White/Caucasian 
 
24 (38.7) 
 
38 (61.3) 
 
62 (100) 
 
 
African American/ 
Black 
 
4 (30.76) 
 
9 (69.2) 
 
13 (100) 
 Total 40 (39.2) 62 (60.8) 102 (100) 
Where N=No. of patients
14 
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Chapter 5: Discussion 
 
 
Prevalence of Anxiety and Depression 
 
 
This study was conducted with cancer patients who were currently receiving some 
treatment for the progression of their cancer. Out of 151 who attempted to respond to the survey, 
only 102 valid and complete responses (after excluding the incomplete and dropout responses) 
were collected and analyzed. In this study, the majority of cancer patients were in the age group 
of 60+ years (46.08%) followed by age group 45–59 years (36.27%). Among those who 
responded to the survey, 59 were females and 43 were males (Table 1). Ninety-six percent 
(symptomatic anxiety) and 69.6% (symptomatic depression) of patients had symptoms of anxiety 
and depression, respectively (Table 2). Furthermore, cancer patients experienced a higher 
frequency of anxiety than depression. This finding is supported by a study conducted in India 
with only breast cancer patients (Srivastava & Ahmad Ansari, 2015), where patients experienced 
more anxiety problems than depression. But contrasting, a study conducted by Hong and Tian 
(2013) determined depression to be a more important psychological problem than anxiety in 
cancer patients (Hong & Tian, 2013). According to Khalil et al. (2016), healthy normal people 
also may experience some anxiety and fear as part of their life. However, the high frequency of 
anxiety in cancer patients may be due to physical symptoms caused by cancer itself, like 
sweating, shortness of breath, dizziness, etc. These symptoms may be due to excessive fear about 
the cancer progression or the impact of the illness. Patients with anxiety may also experience 
depression; however, depression can make anxiety worse and vice versa (National 
Comprehensive Cancer Network [NCCN], 2012; https://www.nccn.org). 
 
 
In this study, age, ethnicity, type of cancer, and type of treatment the patient received had 
no influence on the occurrence of anxiety (P > .05). The only significant difference was shown to
15 
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be between anxiety and gender (P < .05). On the other hand, age, gender, ethnicity, type of 
cancer, and type of treatment the patient received had no influence on the occurrence of 
depression (P > .05). The result indicates that the age of the patients has no significant influence 
on the prevalence of anxiety and depression. However, according to Cohen (2014), the intensity 
of the symptoms of depression and anxiety of cancer patient is seen more in the older age group. 
Anxiety and depression affect more of the older people in the society (Surakarn, Saenubol, & 
Charupheng, 2016; Graves et al., 2007). 
 
There is a significant relationship proved between anxiety and gender by independent t- 
test, as females experience more anxiety problems during their cancer treatment than males (p = 
.0144, p < .05 significantly related at CI = 95%). This is in accordance with the previous study 
result where women showed higher rates of anxiety and depression than seen in men (Linden, 
Vodermaier, MacKenzie, & Grieg, 2012). Fifty-nine percent females scored 8 and above on the 
Hospital Anxiety and Depression Scale (HADS), indicating the symptoms of anxiety, whereas 
40.8% of males were experiencing symptomatic anxiety. Saiz González et al. (2009) reported 
that women are more likely to report their psychological symptoms than men are. There is no 
detectable difference between gender and depression, which is in accordance with the study 
result of Khalil et al. (2016), which has proved that, gender is not a significant contributor to 
depression and anxiety in cancer patients. These results contradict a study by West et al. (2015) 
that indicated significant gender differences in male and female anxiety and depression in cancer 
patients. 
 
Furthermore, based on ethnicity, no significant differences were detected between 
ethnicity and anxiety. These results contradict the study result of Asnaani, Richey, Dimaite, 
Hinton, and Hofmann (2010), where White/Caucasian people were more likely to be diagnosed
16 
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with anxiety disorders in relation to other ethnicities. Statistical significance was not detected 
between ethnicity and depression. This result contradicts a previous study result, where White/ 
Caucasian individuals who are living in poverty had higher lifetime prevalence rates of major 
depressive disorder than other ethnic groups (Riolo, Nguyen, Greden, & King, 2005). In 
addition, the previous study researchers concluded that African American women live with 
greater stress than White/Caucasian women do, but their coping strategies may make them less 
vulnerable to the impact of chronic strain (Watson, Roberts, & Saunders, 2012). Overall, 30.4% 
of patients are normal, and 69.6% of patients are suffering from depression problems during their 
cancer treatment (see Table 4). 
 
This study demonstrates that type of cancer is not related to the prevalence of anxiety and 
depression. The current research findings contradict the previous research findings of a study at 
the Babol Hospital in Iran, where breast and stomach cancer patients had the highest prevalence 
of anxiety and depression (Nikbakhsh, Moudi, Abbasian, & Khafri, 2014). Another study 
reported that patients with lung, esophagus, and cervical cancer are most affected with 
depression (Hong & Tian, 2013). Breast surgery, body image, cancer spreading, death, and 
health issues result in the highest prevalence of anxiety and depression in breast patients 
(Baqutayan, 2012; Nikbakhsh, Moudi, Abbasian, & Khafri, 2014). Another study reported that 
the high frequency of anxiety and depression in lung cancer patients is associated with their 
physical symptoms like a cough, dyspeao, haemoptysis, etc. (Buchanan, Milroy, Baker, 
Thompson, & Levack, 2009). Colostomy consequences, like fatigue, weight loss, and disease 
severity, suggest the evidence of anxiety and depression in gastrointestinal cancer patients 
(Bullen et al., 2012). There was no statistical significance seen between anxiety/depression and 
type of cancer treatment. The current findings contradict the previous research findings, where
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patients who received chemotherapy had the highest prevalence of both anxiety and depression 
 
(Nikbakhsh, Moudi, Abbasian, & Khafri, 2014). 
 
 
Anxiety and Depression Treatment 
 
 
Of the respondents, 36.2% did not discuss their psychological problems with their 
oncologist. The total number of patients that received treatment for both depression and anxiety 
represent 39.2% of all the patients. Forty out of 65 patients who discussed their anxiety and 
depression received some treatment for their anxiety and depression reduction (see Table 7). The 
reluctance of oncologists to suggest a treatment for anxiety and depression may be due to the fact 
that although the majority of psychological issues in oncology is in response to the psychological 
stressor of having a life-threatening illness, some psychological/psychiatric issues are 
biologically induced or result from other medications (McFarland & Holland, 2016). Moreover, 
in a previous study of the prevalence of depression in cancer patients, researchers found that, 
although patients were diagnosed as being depressed and referred for psychiatric consultation, 
the prevalence of major depression still ranged from 9% to 58% (Massie, Lloyd-Williams, 
Irving, & Miller, 2010). 
 
Of the patients that received treatment, 50% of them were in the 18–44 age group 37.8% 
were 45–59 years of age, and 36.2% were over age 60. The trend indicates that the younger 
patients were more likely to receive treatment for anxiety and depression than older patients. 
Based on the depression scores (see Table 4), younger patients (18–44) reported a lower 
percentage of depression than older patients (45 and above), but 50% of younger patients 
received medications for their anxiety and depression. This study result is similar to a previous 
research result reported by Fischer, Wei, Solberg, Rush, and Heinrich (2003), which showed that 
physicians were more likely to diagnose depression in younger patients and ask about current
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symptoms of depression, alcohol problems, and suicide risk than in older patients. Depressed 
elderly patients were less likely to be given a prescription for any medication for depression 
compared to younger depressed patients (Fischer et al., 2003). Based on gender, 46.5% and 
33.9% of males and females received treatment for anxiety and depression, respectively. Females 
have much higher symptomatic depression (63.4%) than males, but out of 57.8% of females 
responded to the survey, only 33.9% received treatment. The oncologist should keep in mind 
while treating the patient for anxiety or depression, female patients experience more 
psychological problems than men, so women need more attention. Lastly, with relation to the 
ethnicity of the patients who received treatment, American Indian patients represented the 
highest percentage at 62.5% followed by Asians at 46.6%. Caucasians represented 38.7 %, while 
African American/Black patients were 30.76%. Of the Hispanic patients in the study, none 
received treatment for anxiety or depression. Further, African American/Black and Hispanics 
were less likely to show anxiety and depression related disorders. This finding is in accordance 
with the study report by Lagomasino, Stockdale, and Miranda (2011), where African American/ 
Black and Hispanic were less likely to receive antidepressant prescriptions or any care for 
depression or anxiety when compared to White/Caucasian people. Overall, 60.8% patients 
reported that no treatment was recommended for anxiety or depression by their oncologist.
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Chapter 6: Conclusion 
 
 
The majority of cancer patients are distressed due to their health status despite the 
advancement of new technologies for cancer treatment. These patients are emotionally disturbed, 
which in turn contributes to psychiatric problems such as anxiety and depression. The findings of 
this study show the significance of assessing the psychological conditions of cancer patients 
before treatment. This calls for the healthcare providers to not only provide treatment to the 
cancer patients but also assess their psychological status. This would assist in minimizing the 
psychiatric symptoms while delivering effective care treatment among the cancer patients. In 
case, the conditions become worse, the oncologists can refer the patients to psychologists or any 
social support groups for effective management. Anxiety and depression have a great effect on 
the feeling of cancer patients and it leads to high level of coping mechanisms. Managing the 
symptoms of anxiety and depression in cancer patients helps in promoting their quality of life 
and improving the prognosis of the disease. As such, assessing the psychological status of cancer 
patients before treatment should be one of the key concerns for the oncologists and other 
healthcare professionals. Some limitations of the study should be briefly mentioned. There was 
no statistical significance proved between anxiety/depression with other demographic criteria 
and other cancer clinical data. Two possible explanations exist for the lack of detectable 
differences between psychological problems and age, ethnicity, gender, type of cancer and type 
of cancer treatment. Firstly, it is possible that there were no significat differences. Secondly, 
statistical tests provided little power to detect the difference between the variables due to high 
variability and insufficient sample size. The patients were not questioned about their past 
psychiatric history of anxiety and depression. Future studies should examine rates of anxiety and 
depression before and after the treatment in cancer patients in a large diverse population. Those
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results will help to conclude whether the treatment helps to reduce anxiety and depression in 
cancer patients. In conclusion, the prevalence of anxiety and depressive disorders is higher in 
cancer patients, but the treatment rate by physicians is low.
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Appendix C: Sample Survey Form 
 
 
 
Dear Sir or Madam, 
You are invited to participate in a survey on "Patient’s perception of cancer related 
Depression/Anxiety during their treatment”. The survey is being conducted as a part of the 
Thesis requirement for a Master’s degree, by Ms. Nisha Devi Muthu Krishnan from Eastern 
Michigan University. 
 
In this survey, patients with cancer are asked to answer questions about emotional issues during 
their cancer treatment. The survey responses will be used to assess the level of depression and/or 
anxiety in cancer patients. 
 
Informed Consent Agreement 
 
Purpose: The purpose of this research study is to find out the prevalence rate of anxiety and 
depression in cancer patients during their treatment. 
 
Funding: This research is unfunded. 
 
Study Procedures: Participation in this study involves completing an online survey. It should take 
10 minutes to complete the questionnaire. 
 
Risks: There are no foreseeable risks associated with this project. Some of the survey questions 
are personal in nature, about your cancer and may make you feel uncomfortable. You do not 
have to answer any questions that make you uncomfortable or that you do not want to answer. 
 
Benefits: You will not directly benefit from participating in this research. Benefits to future 
cancer patients, their psychosocial issues will also be given importance besides getting treatment 
for their tumor. 
 
Confidentiality: Your survey responses will be strictly confidential; we will not collect your 
name and other personal identifiers. Your information will be stored in a password-protected 
computer file. Data from this research will be reported only in aggregate. The results of this 
research may be published or used for teaching. 
 
Compensation: Participants will not be compensated by any means. 
 
Contact Information: If you have any questions about the research, you can contact the Principal 
Investigator, Nisha Devi Muthu Krishnan, at nmuthukr@emich.edu or by phone at 248-345- 
1241. You can also contact Nisha’s adviser, Dr. Stephen Sonstein, at ssonstein@emich.edu or by 
phone at 734-487-1238. 
 
For questions about your rights as a research participant, you can contact the Eastern Michigan 
University Office of Research Compliance at human.subjects@emich.edu or by phone at 
734-487-3090.
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Voluntary participation 
 
Participation in this research study is your choice. You may choose not to participate. If you 
decide to participate in this research survey, you may withdraw at any time by clicking close or 
done button. 
 
*ELECTRONIC CONSENT: Clicking on the "agree" button below indicates that: 
 
•          You have read the above information 
•          You voluntarily agree to participate 
•          You are at least 18 years of age 
Agree 
 
 
 
Are you currently receiving cancer treatment? 
1.  Yes 
2.  No 
Age 
 
1.  18-29 
2.  30-44 
3.  45-59 
4.  60+
 
Gender 
1.  Male 
2.  Female 
 
Which race/ethnicity best describes you? 
1.  American Indian or Alaskan Native 
2.  Asian / Pacific Islander 
3.  Hispanic 
4.  White/Caucasian 
5.  Black or African American 
6.  Other    
 
Please mention your type of cancer (Select all that apply) 
 
1.  Breast 
2.  Prostate 
3.  Gastrointestinal 
4.  Leukemia/lymphoma 
5.  Lung 
6.  Skin 
7.  Bladder/kidney 
8.  Other    
What type of treatment are you taking for your cancer? (Select all that apply)
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1.  Chemotherapy 
2.  Radiation therapy 
3.  Surgery 
4.  Combination therapy 
5.  Other 
 
How have you been feeling in the past week (Anxiety related)? 
 
 Yes 
definitely 
(3) 
Yes 
sometimes 
(2) 
No, not 
much (1) 
No, not at 
all (0) 
I feel tense or wound up ❏ ❏ ❏ ❏ 
I get a sort of frightened feeling as if something 
bad is about to happen ❏ ❏ ❏ ❏ 
Worrying thoughts go through my mind ❏ ❏ ❏ ❏ 
I can sit at ease and feel relaxed ❏ ❏ ❏ ❏ 
I get a sort of frightened feeling like butterflies in 
the stomach ❏ ❏ ❏ ❏ 
I feel restless and have to be on the move ❏ ❏ ❏ ❏ 
I get sudden feelings of panic ❏ ❏ ❏ ❏ 
 
 
How have you been feeling in the past week (Depression related)? 
 
 Yes 
definitely 
(0) 
Yes 
Sometimes 
(1) 
No, not 
much (2) 
No, not at 
all (3) 
I still enjoy the things I used to enjoy ❏ ❏ ❏ ❏ 
I can laugh and see the funny side of things ❏ ❏ ❏ ❏ 
I feel cheerful ❏ ❏ ❏ ❏ 
I feel as if I am slowed down ❏ ❏ ❏ ❏ 
I have lost interest in my appearance ❏ ❏ ❏ ❏ 
I look forward with enjoyment to things ❏ ❏ ❏ ❏ 
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I can enjoy a good book or radio or TV 
programme ❏ ❏ ❏ ❏ 
 
 
Have you ever discussed your depression/anxiety issues with your oncologists? 
1.  Yes 
2.  No 
 
Did you receive any treatment for your depression/anxiety? 
1.  Yes 
2.  No 
